Advertisement

Psychopharmacology

, Volume 178, Issue 2–3, pp 161–166 | Cite as

The astroglial protein S100B and visually evoked event-related potentials before and after antidepressant treatment

  • Guenter HetzelEmail author
  • Olaf Moeller
  • Stefan Evers
  • Andreas Erfurth
  • Gerald Ponath
  • Volker Arolt
  • Matthias Rothermundt
Original Investigation

Abstract

Rationale

S100B is an astrocytic, calcium-binding protein which in nanomolar concentrations has neuroprotective and regenerating effects on neurons and glial cells. Increased levels have been shown to be positively correlated with therapeutic response in major depression. Event-related potentials (ERP) have been reported to be impaired in depressed patients.

Objectives

The aim of our study was to assess the relationship between S100B and visually evoked ERP in depression.

Methods

ERP and S100B serum concentration were studied in 18 patients with major depression, before and after 4 weeks of antidepressant treatment.

Results

The S100B concentration in patients was increased at intake and after 4 weeks of treatment compared to healthy controls. Initially increased P3-latency normalized and P2-latency significantly decreased after 4 weeks of treatment, although only in patients with clearly elevated initial S100B levels (mean plus 2 SD of the healthy controls).

Conclusion

The neuroregenerative activity of moderately increased S100B levels in major depression might be a factor contributing to a decrease of prolonged ERP parameters in major depression during antidepressant treatment.

Keywords

S100B Major depression Event-related potentials Reboxetine Citalopram 

References

  1. Arolt V, Peters M, Erfurth A, Wiesmann M, Missler U, Kirchner H, Rothermundt M (2003) S100B and response to treatment in major depression: a pilot study. Eur Neuropsychopharmacol 13:235–239CrossRefPubMedGoogle Scholar
  2. Bange F, Bathien N (1998) Visual cognitive dysfunction in depression: an event-related potential study. Electroencephalogr Clim Neurophysiol 108:472–481CrossRefPubMedGoogle Scholar
  3. Blackwood DH, Whalley LJ, Christie JE, Blackburn IM, St Clair DM, McInnes A (1987) Changes in auditory P3 event-related potential in schizophrenia and depression. Br J Psychiatry 150:154–160PubMedGoogle Scholar
  4. Bruder GE, Towey JP, Stewart JW, Friedman D, Tenke C, Quitkin FM (1991) Event-related potentials in depression: influence of task, stimulus hemifield and clinical features on P3 latency. Biol Psychiatry 30:233–246CrossRefPubMedGoogle Scholar
  5. Dierks T, Frolich L, Ihl R, Maurer K (1994) Event-related potentials and psychopharmacology. Cholinergic modulation of p 300. Pharmacopsychiatry 27:72–74PubMedGoogle Scholar
  6. Dietrich DE, Hauser U, Peters M, Zhang Y, Wiesmann M, Hasselmann M, Rudolf S, Jüngling O, Kirchner H, Münte T, Arolt V, Emrich HM, Sönke J, Rothermundt M (2004) Target evaluation processing correlates with serum levels of nerve tissue protein S100B in patients with remitted major depression. Neurosci Lett 354:69–73CrossRefPubMedGoogle Scholar
  7. Donato R (2001) S100: a multigenetic family of calcium-modulated proteins of EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol 33:637–668CrossRefPubMedGoogle Scholar
  8. Evers S, Quibeldey F, Grotemeyer KH, Suhr B, Husstedt IW (1999) Dynamic changes of cognitive habituation and serotonin metabolism during the migraine interval. Cephalalgia 19:485–491CrossRefPubMedGoogle Scholar
  9. Evers S, Böckermann I, Nyhuis PW (2001) The impact of transcranial magnetic stimulation on cognitive processing: an event-related potential study. Neuroreport 12:2915–2918CrossRefPubMedGoogle Scholar
  10. Gangadhar BN, Ancy J, Janakiramaiah N, Umapathy C (1993) P300 amplitude in non-bipolar, melancholic depression. J Affect Disord 28:57–60CrossRefPubMedGoogle Scholar
  11. Grabe HJ, Ahrens N, Rose HJ, Keller C, Freyberger HJ (2001) Neurotrophic factor S100beta in major depression. Neuropsychobiology 44:88–90CrossRefPubMedGoogle Scholar
  12. Halgren E, Squires NK, Wilson CL, Rohrbaugh JW, Babb TL, Crandall PH (1980) Endogenous potentials generated in the Human hippocampal formation and amygdala by infrequent events. Science 210:803–805PubMedGoogle Scholar
  13. Hamilton M (1967) Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296PubMedGoogle Scholar
  14. Hegerl U, Gallinat J, Juckel G (2001) Event-related potentials: do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62:93–100CrossRefPubMedGoogle Scholar
  15. Hetzel G, Moeller O, Erfurth A, Michael N, Rothermundt M, Arolt V, Evers S (2004) The impact of the selective monoamine reuptake inhibitors reboxetine and citalopram on visually-evoked event-related potentials in depressed patients. Pharmacopsychiatry (in press)Google Scholar
  16. Himani A, Tandon OP, Bhatia MS (1999) A study of P300-event related evoked potential in the patients of major depression. Ind J Physiol Pharmacol 43:367–372Google Scholar
  17. Lara DR, Gama CS, Belmonte-de-Abreu P, Portela LV, Goncalves CA, Fonseca M, Hauck S, Souza DO (2001) Increased serum S100B protein in schizophrenia: a study in medication-free patients. J Psychiatr Res 35:11–14CrossRefPubMedGoogle Scholar
  18. Machado-Vieira R, Lara DR, Portela LV, Goncalves CA, Soares JC, Kapczinski F, Souza DO (2002) Elevated serum S100B protein in drug-free bipolar patients during first manic episode: a pilot study. Eur Neuropsychopharmacol 12:269–272CrossRefPubMedGoogle Scholar
  19. Manji HK, Drevets WC, Charney DS (2001) The cellular neurobiology of depression. Nat Med 7:541–547CrossRefPubMedGoogle Scholar
  20. Mulert C, Juckel G, Augustin H, Hegerl U (2002) Comparison between the analysis of the loudness dependency of the auditory N1/P2 component with LORETA and dipole source analysis in the prediction of treatment response to the selective reuptake inhibitor citalopram in major depression. Clin Neurophysiol 113:1566–1572CrossRefPubMedGoogle Scholar
  21. Nelson CA, Collins PF, Torres F (1991) P300 brain activity in seizure patients preceding temporal lobectomy. Arch Neurol 48:141–147PubMedGoogle Scholar
  22. Okada YC, Kaufman L, Williamson SJ (1983) The hippocampal formation as a source of the slow endogenous potentials. Electroencephalogr Clin Neurophysiol 55:417–426CrossRefPubMedGoogle Scholar
  23. Paige SR, Hendricks SE, Fitzpatrick DF, Balogh S, Burke WJ (1995) Amplitude/intensity functions of auditory event-related potentials predict resposiveness to bupropion in major depression disorder. Psychopharmacol Bull 31:243–248PubMedGoogle Scholar
  24. Pascual-Leone A, Rubio B, Pallardo F, Catala MD (1996) Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression. Lancet 348:233–237CrossRefPubMedGoogle Scholar
  25. Rothermundt M, Missler U, Arolt V, Peters M, Leadbeater J, Wiesmann M, Rudolf S, Wandinger KP, Kirchner H (2001a) Increased S100B blood levels in unmedicated and treated schizophrenic patients are correlated with negative symptomatology. Mol Psychiatry 6:445–449CrossRefPubMedGoogle Scholar
  26. Rothermundt M, Arolt V, Wiesmann M, Missler U, Peters M, Rudolf S, Kirchner H (2001b) S100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord 66:89–93CrossRefPubMedGoogle Scholar
  27. Rothermundt M, Peters M, Prehn JH, Arolt V (2003) S100B in brain damage and neurodegeneration. Microsc Res Tech 60:614–632CrossRefPubMedGoogle Scholar
  28. Rothermundt M, Ponath G, Glaser T, Hetzel G, Arolt V (2004) S100B serum levels and long-term improvement of negative symptoms in patients with schizophrenia. Neuropsychopharmacology (in press). Advance online publication DOI  10.1038/sj.npp.1300403
  29. Schroeter ML, Abdul-Khaliq H, Diefenbacher A, Blasig IE (2002) S100B is increased in mood disorder and may be reduced by antidepressive treatment. Neuroreport 13:1675–1678CrossRefPubMedGoogle Scholar
  30. Simson R, Vaughn HG, Ritter W (1977) The scalp topography of potentials in auditory and visual discrimination tasks. Electroencephalogr Clin Neurophysiol 42:528–535CrossRefPubMedGoogle Scholar
  31. Vandoolaeghe E, van Hunsel F, Nuyten D, Maes M (1998) Auditory event related potentials in major depression: prolonged P300 latency and increased P200 amplitude. J Affect Disord 48:105–113CrossRefPubMedGoogle Scholar
  32. Wittchen H-O, Pfister H (1997) Diagnostisches expertensystem für psychische Störungen DIA-X. SWETS Test Services, FrankfurtGoogle Scholar
  33. Yanai I, Fujikawa T, Osada M, Yamawaki S, Touhouda Y (1997) Changes in auditory P300 in patients with major depression and silent cerebral infarction. J Affect Disord 46:263–271CrossRefPubMedGoogle Scholar
  34. Yingling CD, Hosobuchi Y (1984) A subcortical correlate of P300 in man. Electroencephalogr Clin Neurophysiol 59:72–76CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • Guenter Hetzel
    • 1
    Email author
  • Olaf Moeller
    • 1
  • Stefan Evers
    • 2
  • Andreas Erfurth
    • 1
  • Gerald Ponath
    • 1
  • Volker Arolt
    • 1
  • Matthias Rothermundt
    • 1
  1. 1.Department of PsychiatryUniversity of MuensterMuensterGermany
  2. 2.Department of NeurologyUniversity of MuensterMuensterGermany

Personalised recommendations